In animal models employed to study SARS, young mice developed lethal disease featured by pulmonary oedema, diffuse alveolar damage and excessive influx of monocytes/macrophages accompanied by delayed interferone-α/β (IFN-α/β) response, whereas targeting IFN signaling showed protective effects and better prognositic outcomes [4]. This evidence concerns the gene IFNA1 and severe acute respiratory syndrome.